| Health / Medical Topics |
Anti-VEGF Anticalin PRS-050-PEG40
A pegylated, proprietary lipocalin that targets human vascular endothelial growth factor (VEGF), with potential antineoplastic activity. Pegylated anti-VEGF anticalin PRS-050 specifically targets and binds to VEGF receptor 2 (VEGFR2 or KDR), thereby preventing its activity. This may inhibit angiogenesis and eventually reduce tumor cell growth. (NCI Thesaurus)
YOU MAY ALSO LIKE
Natural or synthetic Anti-ulcer Agents relieve and reduce the symptoms of ulcers in the stomach and upper small intestine, systemically and locally,…
A humanized monoclonal antibody directed against the apoptotic ligand TNF-like weak inducer of apoptosis (TWEAK) with potential antineoplastic activity. Anti-TWEAK monoclonal antibody…
Drug treatment to reduce the activity of tumor necrosis factor, particulary to control inflammation in disease modalities.
An antibody drug conjugate containing the humanized monoclonal antibody, hRS7, against tumor-associated calcium signal transducer 2 (TACSTD2 or TROP2) and linked to…
A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL-R2 on the surface…
A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL R1 on the…
